PRKR vs. INSM
Remeber when the Markman hearing went against Insmed? We tried to ignore the obvious dire straights that Insmed was in based on our own focus to the reality of Iplex. Well, Parker has kicked QCOM's butt in the Markman on 90 patents! And treble damages are a distinct possibility. PRKR hasn't had any revenues for all these years because QCOM stole their technology and then profited to the tune of billions in cell phone chip production.
Back to Insmed: In the same timeframe as PRKR's potential big win, we are going to get Arikace data from the phase 3, Russell inclusion and possibly news on the Iplex/premiplex front that produces revenue. Also, Arikace is going to become available in the 2nd half of this year on a Compassionate Use basis, ahead of potential FDA approval, also creating revenue.
I see both these stocks reaching at least 20 if everything falls into place, but Insmed has even less risk, IMO.
ive never know someone so consistently incorrect continue to offer their almost always wrong (90+ percent)commentary about future stock price..remember when you said "insm will triple from here..i cant tell you why" and when pressed your insight was "because I can read"..simply amazing